{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:41:04Z","timestamp":1794109264994,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jbo.2025.100695","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:36:48Z","timestamp":1749757008000},"page":"100695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Regulatory role of the METTL3\/MALAT1 axis in multiple myeloma progression"],"prefix":"10.1016","volume":"53","author":[{"given":"Xiaohong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jbo.2025.100695_b0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin. Oncol."},{"issue":"3","key":"10.1016\/j.jbo.2025.100695_b0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.soncn.2017.05.012","article-title":"Pathobiology and diagnosis of multiple myeloma","volume":"33","author":"Brigle","year":"2017","journal-title":"Semin. Oncol. Nurs."},{"issue":"1","key":"10.1016\/j.jbo.2025.100695_b0015","first-page":"58","article-title":"Haematology: multiple myeloma","volume":"19","author":"Medical Masterclass, c","year":"2019","journal-title":"Clin. Med. (Lond.)"},{"issue":"Suppl 1","key":"10.1016\/j.jbo.2025.100695_b0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hon.2586","article-title":"Multiple myeloma: every year a new standard?","volume":"37","author":"Rajkumar","year":"2019","journal-title":"Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.jbo.2025.100695_b0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ymthe.2024.12.003","article-title":"Exploring the methyl-verse: dynamic interplay of epigenome and m6A epitranscriptome","volume":"33","author":"Pilala","year":"2025","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jbo.2025.100695_b0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10238-025-01624-z","article-title":"N6-methyladenosine-mediated upregulation of H19 promotes resistance to bortezomib by modulating the miR-184\/CARM1 axis in multiple myeloma","volume":"25","author":"Wang","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"6","key":"10.1016\/j.jbo.2025.100695_b0035","first-page":"1631","article-title":"METTL3 plays multiple functions in biological processes","volume":"10","author":"Liu","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.jbo.2025.100695_b0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m(6)A Methyltransferase METTL3 promotes translation in human cancer cells","volume":"62","author":"Lin","year":"2016","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.jbo.2025.100695_b0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-019-1036-9","article-title":"METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner","volume":"18","author":"Han","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.jbo.2025.100695_b0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-019-1038-7","article-title":"METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbo.2025.100695_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109964","article-title":"Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2","volume":"125","author":"Zhou","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.jbo.2025.100695_b0060","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.18632\/aging.102950","article-title":"m(6)A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145\/FAK pathway","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.jbo.2025.100695_b0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12935-021-02113-5","article-title":"The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1\/miR-26b\/HMGA2 axis","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.jbo.2025.100695_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188502","article-title":"Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer","volume":"1875","author":"Goyal","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"10","key":"10.1016\/j.jbo.2025.100695_b0075","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/CM9.0000000000003090","article-title":"Long non-coding RNA MALAT1 in hematological malignancies and its clinical applications","volume":"137","author":"Zhang","year":"2024","journal-title":"Chin. Med. J. (Engl)"},{"issue":"1","key":"10.1016\/j.jbo.2025.100695_b0080","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s42003-024-06918-8","article-title":"Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma","volume":"7","author":"Yu","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbo.2025.100695_b0085","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1186\/1471-2407-14-809","article-title":"MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression","volume":"14","author":"Cho","year":"2014","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.jbo.2025.100695_b0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjh.14882","article-title":"Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma","volume":"179","author":"Handa","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.jbo.2025.100695_b0095","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/s41375-018-0104-2","article-title":"Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma","volume":"32","author":"Hu","year":"2018","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.jbo.2025.100695_b0100","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","article-title":"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity","volume":"32","author":"Amodio","year":"2018","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.jbo.2025.100695_b0105","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1158\/0008-5472.CAN-19-1077","article-title":"Targeting of CD38 by the tumor suppressor miR-26a serves as a novel potential therapeutic agent in multiple myeloma","volume":"80","author":"Hu","year":"2020","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.jbo.2025.100695_b0110","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","article-title":"International myeloma working group recommendations for the diagnosis and Management of Myeloma-Related Renal Impairment","volume":"34","author":"Dimopoulos","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.jbo.2025.100695_b0115","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1089\/thy.2017.0665","article-title":"MicroRNA-222 promotes invasion and metastasis of papillary thyroid cancer through targeting protein phosphatase 2 regulatory subunit B alpha expression","volume":"28","author":"Huang","year":"2018","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.jbo.2025.100695_b0120","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.18632\/oncotarget.23336","article-title":"LncRNA Gas5 acts as a ceRNA to regulate PTEN expression by sponging miR-222-3p in papillary thyroid carcinoma","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.jbo.2025.100695_b0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.21037\/atm.2019.10.71","article-title":"miR-3619-3p promotes papillary thyroid carcinoma progression via Wnt\/beta-catenin pathway","volume":"7","author":"Yu","year":"2019","journal-title":"Ann Transl Med"},{"issue":"23","key":"10.1016\/j.jbo.2025.100695_b0130","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1002\/cam4.3570","article-title":"LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p\/MDM4 axis","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.jbo.2025.100695_b0135","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1186\/s12885-020-07515-8","article-title":"Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192\/XIAP axis","volume":"20","author":"Li","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbo.2025.100695_b0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/OTT.S431810","article-title":"METTL3\/MALAT1\/ELAVL1 Axis promotes tumor growth in Ovarian cancer","volume":"17","author":"Xiong","year":"2024","journal-title":"Onco Targets Ther"},{"issue":"6","key":"10.1016\/j.jbo.2025.100695_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0255-x","article-title":"microRNA-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model","volume":"51","author":"Yao","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jbo.2025.100695_b0150","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3389\/fgene.2020.00955","article-title":"The m6A Methyltransferase METTL3 is functionally implicated in DLBCL development by regulating m6A modification in PEDF","volume":"11","author":"Cheng","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.jbo.2025.100695_b0155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12935-020-01549-5","article-title":"Long non-coding RNA MALAT1 regulates oxaliplatin-resistance via miR-324-3p\/ADAM17 axis in colorectal cancer cells","volume":"20","author":"Fan","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"8","key":"10.1016\/j.jbo.2025.100695_b0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5694\/mja2.50129","article-title":"Biology and therapy of multiple myeloma","volume":"210","author":"Joshua","year":"2019","journal-title":"Med. J. Aust."},{"issue":"7","key":"10.1016\/j.jbo.2025.100695_b0165","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","article-title":"METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jbo.2025.100695_b0170","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12943-019-1065-4","article-title":"METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer","volume":"18","author":"Yue","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbo.2025.100695_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144076","article-title":"N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2","volume":"722","author":"Wang","year":"2020","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.jbo.2025.100695_b0180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s13046-019-1408-4","article-title":"Upregulated METTL3 promotes metastasis of colorectal cancer via miR-1246\/SPRED2\/MAPK signaling pathway","volume":"38","author":"Peng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.jbo.2025.100695_b0185","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41388-019-0683-z","article-title":"The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-kappaB\/MYC signaling network","volume":"38","author":"Cheng","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.jbo.2025.100695_b0190","first-page":"3197","article-title":"METTL3 serves an oncogenic role in human ovarian cancer cells partially via the AKT signaling pathway","volume":"19","author":"Liang","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jbo.2025.100695_b0195","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.2147\/OTT.S226796","article-title":"RNA m(6)A Methyltransferase METTL3 promotes the growth of prostate cancer by regulating hedgehog pathway","volume":"12","author":"Cai","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"2","key":"10.1016\/j.jbo.2025.100695_b0200","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00432-020-03127-8","article-title":"Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p\/SOX13 axis","volume":"146","author":"Liu","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jbo.2025.100695_b0205","article-title":"Repression of multiple myeloma cell growth in vivo by single-wall Carbon nanotube (SWCNT)-delivered MALAT1 antisense oligos","volume":"142","author":"Lin","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"10","key":"10.1016\/j.jbo.2025.100695_b0210","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/1440-1681.12804","article-title":"Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma","volume":"44","author":"Liu","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"9","key":"10.1016\/j.jbo.2025.100695_b0215","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1002\/jcp.26383","article-title":"LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p\/HMGB1 axis","volume":"233","author":"Wu","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.jbo.2025.100695_b0220","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","article-title":"The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells","volume":"73","author":"Gutschner","year":"2013","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jbo.2025.100695_b0225","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.prp.2019.01.011","article-title":"Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells","volume":"215","author":"Dai","year":"2019","journal-title":"Pathol. Res. Pract."},{"issue":"3","key":"10.1016\/j.jbo.2025.100695_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003368","article-title":"Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB","volume":"9","author":"Tripathi","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jbo.2025.100695_b0235","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fgene.2017.00208","article-title":"Identification of minimal p53 promoter Region regulated by MALAT1 in human lung Adenocarcinoma cells","volume":"8","author":"Tano","year":"2017","journal-title":"Front. Genet."},{"key":"10.1016\/j.jbo.2025.100695_b0240","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8693259","article-title":"LncRNA-MALAT1 regulates cancer glucose metabolism in prostate cancer via MYBL2\/mTOR Axis","volume":"2022","author":"Mu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T11:06:07Z","timestamp":1753959967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137425000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"alternative-id":["S2212137425000363"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100695","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory role of the METTL3\/MALAT1 axis in multiple myeloma progression","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100695"}}